Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524314 | NSE Symbol : | ISIN : INE499G01013 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
19-May-2025	26-May-2025	Accounts	Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Audited Financial Results for quarter and year ended on 31st March 2025 Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held on Monday, the26th day of May, 2025 at 4:30 P.M. has inter- alia: (1) Approved the Audited Financial Results for quarter and year ended 31st March, 2025. We enclose here with a copy of the approved Audited Financial Results along with the Auditor''s Report with unmodified opinions on the aforesaid Audited Financial Results issued by M/s M.A. SHAH & Co., Chartered Accountants (FRN: 112630W), Statutory Auditors of the Company as Annexure-A. (2) Re-Appointment of M/s D.V. Shah, (Membership No.034294), Chartered Accountants( FRN No. 109551W ), as Internal Auditor of the Company for the Financial Year 2025-26. and others (As Per BSE Announcement dated on 26.05.2025)
27-Jan-2025	04-Feb-2025	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve Unaudited Financial Results of the company for the Quarter ended on 31st December 2024. Unaudited Financial Results for quarter ended on 31.12.2024 (As Per BSE Announcement Dated on: 04/02/2025)
18-Oct-2024	28-Oct-2024	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2024 Outcome of Board Meeting held on 28th October, 2024 at 06:00 pm (As per BSE Announcement dated on: 28/10/2024)
02-Aug-2024	09-Aug-2024	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve consideration of Unaudited Financial Results for the quarter ended 30th June 2024 and ensuing 39th AGM Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing RegulationsT) read with Schedule 1T to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., Friday, 09' August, 2024 which commenced at 4:00 p.m. and concluded at 5:00 p.m. for approval of Unaudited Standalone Financial Results for the Quarter ended on June 30, 2024 and decide date of Ensuing AGM (As per BSE Announcement Dated on 09/08/2024)
20-May-2024	29-May-2024	Accounts	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Pursuant to the requirement of Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 29th May 2024 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended on 31st March 2024 (the 'Results'). Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held on Wednesday, the 29th day of May, 2024 at 3:30 P.M. has inter- alia: (1) Approved the Audited Financial Results for quarter and year ended 31st March, 2024. We enclose herewith a copy of the approved Audited Financial Results along with the Auditor's Report with unmodified opinions on the aforesaid Audited Financial Results issued by M/s M.A. SHAH & Co., Chartered Accountants (FRN: 112630W), Statutory Auditors of the Company as Annexure-A. (2) Re-Appointment of M/s D.V. Shah, (Membership No. 034294), Chartered Accountants (FRN No. 109551W), as Internal Auditor of the Company for the Financial Year 2024-25. Read less.. Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held on Wednesday, the 29th day of May, 2024 at 3:30 P.M. has inter- alia: (1) Approved the Audited Financial Results for quarter and year ended 31st March, 2024. We enclose herewith a copy of the approved Audited Financial Results along with the Auditor's Report with unmodified opinions on the aforesaid Audited Financial Results issued by M/s M.A. SHAH & Co., Chartered Accountants (FRN: 112630W), Statutory Auditors of the Company as Annexure-A. (2) Re-Appointment of M/s D.V. Shah, (Membership No. 034294), Chartered Accountants (FRN No. 109551W), as Internal Auditor of the Company for the Financial Year 2024-25. Read less.. (As Per BSE Announcement Dated on 29.05.2024) Pursuant to Regulation 42 and 52(8) of SEBI (LODR) Regulations, 2015, please find enclosed Newspaper Publication pertaining to Financial Results of the Company for the year ended on 31st March, 2024, published in Business Standard (English) and Jai Hind (Gujarati). Read less.. (As Per BSE Announcement Dated on 31.05.2024)
22-Mar-2024	29-Mar-2024	Preferential Issue	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 inter alia to consider and approve a proposal for raising of funds by way of issue of equity shares convertible securities and / or any other eligible securities on a preferential basis as may be considered appropriate subject to all such regulatory / statutory approvals as may be required. The Board at its meeting held today has approved the issue of fully convertible warrants on preferential basis (As Per BSE Announcement Dated on: 29/03/2024)
23-Jan-2024	05-Feb-2024	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve Un-audited Financial Results for the quarter and nine months ended on 31st December 2023. As required under Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Un-Audited Standalone Financial Results of the Company for the quarter and nine months ended on 31 st December 2023, together with the Limited Review Reports thereon from the Statutory Auditors, M/s. M.A. Shah & Co. The said results are reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting held today. (As Per BSE Announcement dated on 05.02.2024)
31-Oct-2023	08-Nov-2023	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Un-audited Financial Results of the Company for the quarter and half year ended on 30th September 2023. As required under Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Un-Audited Standalone Financial Results of the Company for the quarter and half year ended 30th September 2023, together with the Limited Review Reports thereon from the Statutory Auditors, M/s. M.A. Shah & CO. Please find attached herewith Un-Audited Standalone Financial Results of the Company for the quarter and half year ended 30th September 2023. (As Per BSE Announcement Dated on 08/11/2023)
21-Jul-2023	11-Aug-2023	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve The Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th June 2023 (the 'Results'). Outcome of Board Meeting held on 11th August 2023 for the Unaudited Financial Results of the Company for the quarter ended on 30th June, 2023. (As Per BSE Announcement Dated on 11.08.2023)
04-May-2023	13-May-2023	Accounts	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2023 inter alia to consider and approve Pursuant to the requirement of Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday 13th May 2023 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended on 31st March 2023 (the 'Results'). We wish to inform you that the following decisions have been taken at the Meeting of the Board of Directors of the Company held today Audited Financial Results for the year ended on March 31, 2023 (As per BSE Announcement Dated on 13/05/2023)
07-Mar-2023	06-Mar-2023	Change in Other Executives	Appointment of Mrs. Ripal Sachinkumar Sukhadiya as the Company Secretary & Compliance Officer of the Company w.e.f 06th March, 2023.
25-Jan-2023	31-Jan-2023	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve Gujarat Terce Laboratories Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31 2022 The outcome of Board Meeting held on January 31, 2023. Unaudited Financial Results for the quarter and nine months ended December 31, 2022. (As Per BSE Announcement dated on 31.01.2023)
03-Nov-2022	14-Nov-2022	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Please take note that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday 14th November 2022 at D-802 The First B/h. Keshavbaug Party Plot Near Shivalik High-Street Vastrapur Ahmedabad -380015 Gujarat at 4.00 p.m. Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., Monday, 14th November 2022 which commenced at 4:00 p.m. and concluded at 7:10 p.m. inter alia, have approved / noted the following Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., Monday, 14th November 2022 which commenced at 4:00 p.m. and concluded at 7:10 p.m. inter alia, have approved the Unaudited Financial Results. (As Per BSE Announcement Dated on 14/11/2022)
27-Jul-2022	05-Aug-2022	Quarterly Results	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 inter alia to consider and approve With reference to the captioned subject please take note that the next meeting of the Board of Directors of the Company will be held on Friday August 05 2022 at D-802 The First B/h. Keshavbaug Party Plot Near Shivalik High-Street Vastrapur Ahmedabad -380015 Gujarat at 4.00 p.m. regarding the following matters: 1. To consider and approve the Unaudited Standalone Financial Results for the quarter ended on June 30 2022 along with the Limited Review Report. 2. To consider any other matter with the permission of the Chair. This is in compliance with the relevant regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Please take note of the same. Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., Friday, 05th August, 2022 which commenced at 4:00 p.m. and concluded at 5:00 p.m. inter alia, have approved / noted the following:- (As per BSE Announcement Dated on 05/08/2022)
19-May-2022	30-May-2022	Accounts	GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve The meeting of the Board of Directors of the Company will be held on Monday May 30 2022 at 11:00 AM at Unit No. D-801-802 The First B/h. Keshavbaug Party Plot Vastrapur Ahmedabad -380015. Gujarat Terce Laboratories Limited ('Company') has submitted to the exchange the Audited Financial Results for the quarter and financial year ended on 31st March, 2022. (As Per BSE Announcement Dated on 30/05/2022)

1 2

LOGIN HERE

Gujarat Terce Laboratories Ltd

Board Meeting